D. E. Shaw & Co »

Cartesian Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $299k 29k 10.42

More positions owned by D. E. Shaw & Co

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Advanced Micro Devices Put Option (AMD)
Amazon (AMZN)
Micron Technology Put Option (MU)
Alphabet Cap Stk Cl C Call Option (GOOG)
Meta Platforms Cl A Call Option (META)
Tesla Motors (TSLA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Put Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Bloom Energy Corp Com Cl A Put Option (BE)
Crowdstrike Hldgs Cl A Put Option (CRWD)
Sandisk Corp (SNDK)

View all positions for D. E. Shaw & Co

Top funds holding Cartesian Therapeutics

Squarepoint Ops
BlackRock
683 Capital Management
Vanguard Capital Management
FMR
Geode Capital Management
AQR Capital Management
Millennium Management
Two Sigma Investments
Marshall Wace
UBS Group
Jupiter Topco
State Street Corporation
Privium Fund Management B.V.
Susquehanna International

View all funds holding Cartesian Therapeutics